pantoprazole has been researched along with Kidney Stones in 1 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cameron, M | 1 |
| Maalouf, NM | 1 |
| Poindexter, J | 1 |
| Adams-Huet, B | 1 |
| Sakhaee, K | 1 |
| Moe, OW | 1 |
1 trial available for pantoprazole and Kidney Stones
| Article | Year |
|---|---|
The diurnal variation in urine acidification differs between normal individuals and uric acid stone formers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Bicarbonates; Biomarkers; Buffers; Circadian R | 2012 |